Literature DB >> 14678776

Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration.

Marjolijn Bornebroek1, Chris De Jonghe, Joost Haan, Samir Kumar-Singh, Steve Younkin, Raymund Roos, Christine Van Broeckhoven.   

Abstract

Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D) is a rare autosomal dominant disorder caused by an amyloid-beta precursor protein (AbetaPP) 693 mutation that clinically leads to recurrent hemorrhagic strokes and dementia. The disease is pathologically characterised by the deposition of Abeta in cerebral blood vessels and as plaques in the brain parenchyma. This study measured the Abeta40 and Abeta42 concentration in plasma of Dutch AbetaPP693 mutation carriers and controls. We found that the Abeta40 concentration was not different between AbetaPP693 mutation carriers and controls. However, the Abeta42 concentration was significantly decreased in the mutation carriers. No correlation exists between the APOE(epsilon)4 allele and the plasma of Abeta40 and Abeta42 levels in HCHWA-D patients. This finding contrasted with the increased concentrations found in Alzheimer's disease. Therefore it is suggested that the Dutch AbetaPP693 mutation located within the Abeta coding region of the AbetaPP gene has a different effect not only on clinical and pathological expression but also on Abeta processing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678776     DOI: 10.1016/j.nbd.2003.08.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.

Authors:  Jitika Rajpoot; Elliot J Crooks; Brandon A Irizarry; Ashley Amundson; William E Van Nostrand; Steven O Smith
Journal:  Biochemistry       Date:  2022-06-06       Impact factor: 3.321

2.  Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.

Authors:  Stuart J McCarter; Timothy G Lesnick; Val J Lowe; Alejandro A Rabinstein; Scott A Przybelski; Alicia Algeciras-Schimnich; Vijay K Ramanan; Clifford R Jack; Ronald C Petersen; David S Knopman; Bradley F Boeve; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; Jonathan Graff-Radford
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.

Authors:  Edward K Agyare; Sarah R Leonard; Geoffry L Curran; Caroline C Yu; Val J Lowe; Anant K Paravastu; Joseph F Poduslo; Karunya K Kandimalla
Journal:  Mol Pharm       Date:  2013-03-05       Impact factor: 4.939

Review 4.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

5.  Cerebral amyloid angiopathy: a systematic review.

Authors:  Alessandro Biffi; Steven M Greenberg
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

Review 6.  Imaging of cerebrovascular pathology in animal models of Alzheimer's disease.

Authors:  Jan Klohs; Markus Rudin; Derya R Shimshek; Nicolau Beckmann
Journal:  Front Aging Neurosci       Date:  2014-03-13       Impact factor: 5.750

7.  Plasma β-amyloid in Alzheimer's disease and vascular disease.

Authors:  Shorena Janelidze; Erik Stomrud; Sebastian Palmqvist; Henrik Zetterberg; Danielle van Westen; Andreas Jeromin; Linan Song; David Hanlon; Cristina A Tan Hehir; David Baker; Kaj Blennow; Oskar Hansson
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

Review 8.  Genetic Risk Factors for Ischemic and Hemorrhagic Stroke.

Authors:  Ganesh Chauhan; Stéphanie Debette
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

9.  Protein fragments: functional and structural roles of their coevolution networks.

Authors:  Linda Dib; Alessandra Carbone
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

Authors:  Chuanhai Cao; Xiaoyang Lin; Monika M Wahi; Eugene A Jackson; Huntington Potter
Journal:  BMC Neurosci       Date:  2008-02-18       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.